Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Apyx Medical Corp changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of APYX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders71163−7
Shares19.6M5.09K21.0M+1.45M (+7.4%)
Value$127.9M$33.0K$123.2M−$4.66M (−3.6%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (20)

Institutions that held Apyx Medical Corp at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to APYX in Q2 2022
InstitutionSharesValue% of portfolio
UBS Group AG881,612$5.17M0.00%
Next Century Growth Investors LLC596,296$3.49M0.46%
Ergoteles LLC160,836$942.0K0.03%
Susquehanna International Group, LLP156,030$914.0K0.00%
Divisadero Street Capital Management, LP101,235$593.0K0.47%
Citadel Advisors LLC95,132$557.0K0.00%
UBS Oconnor LLC85,000$498.0K0.01%
Assenagon Asset Management S.A.82,563$484.0K0.00%
Qube Research & Technologies Ltd26,775$157.0K0.00%
DuPont Capital Management Corp24,971$146.0K0.01%
D. E. Shaw & Co., Inc.24,586$144.0K0.00%
Simplex Trading, LLC20,112$117.0K0.00%
Connor, Clark & Lunn Investment Management Ltd.15,396$90.0K0.00%
Cubist Systematic Strategies, LLC12,377$73.0K0.00%
Laurion Capital Management LP11,981$70.0K0.00%
FNY Investment Advisers, LLC8,319$48.0K0.04%
Kayne Anderson Rudnick Investment Management LLC4,000$23.0K0.00%
Ronald Blue Trust, Inc.1,555$10.0K0.00%
CarsonAllaria Wealth Management, Ltd.222$1.00K0.00%
Credit Suisse AG17$00.00%

Sold out (27)

Institutions that held Apyx Medical Corp at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (1)

Institutions that held Apyx Medical Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APYX in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.5,094$33.0K